Pharmaceutical MedTech Analysis l Report Store l Pharma Intelligence

Germany, Surgical Procedure Volumes

This report presents an overview of selected medical specialties and the number of surgical procedures performed for selected diseases/disorders in the European Union country of Germany.

October 1, 2013

Find out more

Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

$1,995.00

This report presents the disease incidence and prevalence and surgical procedure volumes for selected neurological diseases/disorders and procedures in Italy; incidence and prevalence figures are compared with those of the Benelux countries

December 3, 2012

Find out more

Biomedtracker Q4 2020 Outlook Report

$4,750.00

In this report, we cover catalysts from 35 drugs, devices, diagnostics, and deals expected to occur in Q4 2020. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.

October 9, 2020

Find out more

Global Orthopaedic Markets to 2023

$2,995.00

This report provides an unparalleled 120-country statistical view of the US$36.4 billion orthopaedic device markets. Comprising a pdf report and data set in MS Excel™, the report is rich in stats, tables and graphs and covers market value, market growth in US$/local currency and per capita spending over the last 10 years with 5-year forecasts to 2023 for the trade segments of artificial joints and other orthopaedic products.

July 1, 2019

Find out more

Biomedtracker Q4 2017 Outlook Report

$4,750.00

In this report, we cover catalysts from 21 drugs expected to occur in Q4 2017. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

October 2, 2017

Find out more

Drug Delivery: Inhalation Devices

$4,750.00

This Meddevicetracker report includes a discussion of inhalation devices, products, current/forecast markets, competitors, and opportunities in the global markets for inhalation-based drug delivery devices for the treatment of asthma and COPD and much more.

December 14, 2021

Find out more

Women’s Health: U.S. Markets for Reproductive Management Products

$3,750.00

This report presents market and competitive analyses for selected leading contraceptive and fertility products as well as an overview of the most common types of contraceptives and fertility drugs/treatments available to women in the United States (U.S.) for reproductive management.

September 2, 2013

Find out more

U.S. Disease Incidence and Prevalence

$4,750.00

This comprehensive report examines the etiology and epidemiology, number of hospital discharges, incidence and prevalence, and mortality rates of the most prevalent diseases/disorders in the United States for the years 2000-2010, and 2013.

November 3, 2014

Find out more

MedTech analysis

Germany, Surgical Procedure Volumes

Italy, Neurological Market Opportunities: Disease Incidence and Prevalence, and Surgical Procedure Volumes

Biomedtracker Q4 2020 Outlook Report

Global Orthopaedic Markets to 2023

Biomedtracker Q4 2017 Outlook Report

Drug Delivery: Inhalation Devices

Women’s Health: U.S. Markets for Reproductive Management Products

U.S. Disease Incidence and Prevalence